Clinical Trial Update: Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants? [Phase 2]

View source ↗

Summary

This entry describes an ongoing Phase 2 trial evaluating SMOFlipid, a composite parenteral nutrition lipid emulsion, to prevent progression of parenteral nutrit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Motility Disorder
• Intestinal Failure
• Mucosal Enteropathy
• Parenteral Nutrition Associated Liver Disease
• Short Bowel Syndrome

Drugs mentioned

• SMOFLIPID

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Short Bowel Syndrome, Intestinal Failure | Phase 2 | Status: UNKNOWN